Unilaterally Symptomatic Moyamoya Disease in Children: Long-term Follow-up of 20 Patients

医学 无症状的 烟雾病 搭桥手术 外科 狭窄 冲程(发动机) 脑血流 麻醉 心脏病学 动脉 机械工程 工程类
作者
Shinji Nagata,Toshio Matsushima,Takato Morioka,Koichiro Matsukado,Futoshi Mihara,Tomio Sasaki,Masashi Fukui
出处
期刊:Neurosurgery [Oxford University Press]
卷期号:59 (4): 830-837 被引量:36
标识
DOI:10.1227/01.neu.0000227527.69766.43
摘要

OBJECTIVE: In unilaterally symptomatic moyamoya disease in children, it remains controversial whether bypass surgery should be performed on the asymptomatic side along with on the symptomatic side. We aimed to verify the validity of our strategy of only performing bypass surgery on the symptomatic side. METHODS: Among 91 pediatric patients with moyamoya disease who underwent bypass surgery in our department between 1980 and 2004, 20 with unilateral ischemic symptoms who were followed for more than 60 months were analyzed in the present study. Initially, we only performed bypass surgery on the symptomatic side for all 20 patients. Among these 20 patients, five developed frequent transient ischemic attacks in the initially asymptomatic side and underwent a second bypass surgery on that side (Group A), eight developed sporadic transient ischemic attacks and were followed up without surgery (Group B), and seven did not experience any ischemic symptoms on the asymptomatic side (Group C). RESULTS: In total, 18 patients progressed well without cerebral infarctions after their last surgery, although some showed deterioration of angiographic stenosis and a transient decrease in the regional cerebral blood flow or cerebral perfusion reserve. One patient in Group A had an intraventricular hemorrhage 5 years after the second operation, and one in Group B had a minor stroke on the initially asymptomatic side. CONCLUSION: In unilaterally symptomatic moyamoya disease, bypass surgery for the asymptomatic side can be delayed until the development of ischemic symptoms, such as frequent transient ischemic attacks.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yuyu完成签到,获得积分10
刚刚
2秒前
2秒前
CodeCraft应助秋中雨采纳,获得10
5秒前
YY完成签到 ,获得积分10
5秒前
6秒前
Ava应助wx采纳,获得10
6秒前
枫桥夜泊完成签到,获得积分10
7秒前
7秒前
思源应助有只小狗采纳,获得10
9秒前
9秒前
星辰大海应助科研通管家采纳,获得80
13秒前
深情安青应助科研通管家采纳,获得10
13秒前
大个应助科研通管家采纳,获得10
13秒前
田様应助时尚平凡采纳,获得10
13秒前
13秒前
大个应助科研通管家采纳,获得10
13秒前
CodeCraft应助Yyyy采纳,获得30
13秒前
orixero应助科研通管家采纳,获得10
13秒前
小马甲应助科研通管家采纳,获得10
13秒前
cocolu应助科研通管家采纳,获得10
13秒前
深情安青应助科研通管家采纳,获得10
14秒前
烟花应助科研通管家采纳,获得10
14秒前
领导范儿应助科研通管家采纳,获得10
14秒前
Jasper应助科研通管家采纳,获得10
14秒前
英俊的铭应助科研通管家采纳,获得30
14秒前
14秒前
香蕉觅云应助科研通管家采纳,获得10
14秒前
天天快乐应助科研通管家采纳,获得10
14秒前
1113完成签到,获得积分10
14秒前
15秒前
义气凝阳完成签到,获得积分10
17秒前
盒子应助liangmh采纳,获得10
17秒前
maggie11发布了新的文献求助20
18秒前
18秒前
Fancy完成签到,获得积分10
18秒前
19秒前
19秒前
hautzhl完成签到,获得积分10
19秒前
dd完成签到,获得积分10
19秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Effect of reactor temperature on FCC yield 2000
Introduction to Spectroscopic Ellipsometry of Thin Film Materials Instrumentation, Data Analysis, and Applications 1800
Natural History of Mantodea 螳螂的自然史 1000
A Photographic Guide to Mantis of China 常见螳螂野外识别手册 800
How Maoism Was Made: Reconstructing China, 1949-1965 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3313969
求助须知:如何正确求助?哪些是违规求助? 2946329
关于积分的说明 8529696
捐赠科研通 2621983
什么是DOI,文献DOI怎么找? 1434250
科研通“疑难数据库(出版商)”最低求助积分说明 665190
邀请新用户注册赠送积分活动 650774